Posted: 22 November 2023
A new report from MTPConnect and its Australian Antimicrobial Resistance Network (AAMRNet) highlights the threat to human health posed by the rise of drug-resistant infections and presents recommendations that will equip the Australian healthcare system to fight the superbug pandemic.
Antimicrobial resistance (AMR) has been recognised by the World Health Organization as one of the top 10 public health threats facing humanity with estimates of 10 million people globally dying each year by 2050.
Launched during World Antimicrobial Awareness Week, the new report – Fighting superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections – has been prepared in response to the Australian Parliament’s report, The New Frontier – Delivering better health for all Australians.
From incentives for more home-grown R&D and globally competitive data and market protections to more point-of-care testing for antimicrobial infections, the new report presents nine evidence-based recommendations for practical steps Australia can take to meet the AMR challenge.
With expert advice and input from leading Australian and international experts in AMR, the report highlights the need to take urgent action to protect our health from deadly superbugs.
The report was officially launched today by MTPConnect’s Andrew Bowskill, Co-chair AAMRNet at the BioMelbourne Network event BioForum – New Frontiers: Rethinking Antimicrobial Resistance in Melbourne, where an expert panel of speakers led an important discussion on tackling the rise of drug-resistant infections.
The Fighting Superbugs report was developed by specialist health advisory firm Evohealth, authored by Renae Beardmore, Laura Birchall, Yukti Sharma, John Pilla and Lloyd Sansom.
Established in 2020 and operated by MTPConnect, AAMRNet is Australia’s leading multistakeholder expert group promoting Australia’s role in combating the urgent threat to human health posed by AMR.
